Cf-PWV and TyG Index Study
RIGID-TyG
Correlation Between Carotid-Femoral Pulse Wave Velocity and Triglyceride-Glucose Index and Its Derived Metrics
1 other identifier
observational
800
1 country
1
Brief Summary
This study aims to investigate how metabolic health is related to arterial stiffness and daily blood pressure patterns. High blood pressure is one of the leading causes of heart disease worldwide, but cardiovascular risk is not determined only by average blood pressure values. Changes in blood vessel structure and metabolic function also play an important role in the development of cardiovascular disease. Arterial stiffness reflects how flexible or rigid the arteries are. It can be measured using carotid-femoral pulse wave velocity (cf-PWV), which is considered a reliable and widely used method to assess vascular health. Increased arterial stiffness is associated with aging and higher cardiovascular risk. At the same time, metabolic factors such as insulin resistance and central obesity are strongly linked to vascular damage. The triglyceride-glucose (TyG) index is a simple measure derived from routine blood tests and has been shown to reflect insulin resistance. Additional derived indices that combine TyG with body measurements (such as waist circumference and body mass index) may provide an even more comprehensive evaluation of metabolic risk. Another important aspect of cardiovascular regulation is how blood pressure changes throughout the day. Blood pressure naturally rises in the morning after waking, a phenomenon known as the morning blood pressure surge. When this increase is excessive, it has been associated with a higher risk of cardiovascular events such as stroke and heart attack. This study will evaluate the relationship between metabolic indices, arterial stiffness, and morning blood pressure patterns in adults undergoing ambulatory blood pressure monitoring as part of routine clinical care. The study will include both previously collected data and new participants evaluated using standardized methods. No additional interventions will be performed, and all data will be collected as part of routine clinical evaluation. The results of this study may help improve cardiovascular risk assessment by integrating simple metabolic markers with vascular measurements and daily blood pressure behavior, potentially allowing earlier identification of individuals at higher risk.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 2, 2026
CompletedFirst Posted
Study publicly available on registry
May 15, 2026
CompletedStudy Start
First participant enrolled
July 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2027
Study Completion
Last participant's last visit for all outcomes
July 1, 2028
May 22, 2026
April 1, 2026
1 year
May 2, 2026
May 19, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Carotid-femoral pulse wave velocity (cf-PWV)
Carotid-femoral pulse wave velocity (cf-PWV) will be measured as a marker of arterial stiffness using a validated non-invasive device under standardized conditions. The association between cf-PWV and the triglyceride-glucose (TyG) index will be evaluated.
Baseline
Secondary Outcomes (4)
Morning systolic blood pressure
Average systolic blood pressure during the first two hours after awakening, obtained from 24-hour ambulatory blood pressure monitoring (ABPM).
Morning diastolic blood pressure
Average diastolic blood pressure during the first two hours after awakening, obtained from ABPM.
Sleep-through morning blood pressure surge
Difference between morning systolic blood pressure and the lowest nocturnal systolic blood pressure value.
Prewaking morning blood pressure surge
Difference between morning systolic blood pressure and the average systolic blood pressure during the two hours preceding awakening.
Study Arms (2)
Normotensive participants
Adults with normal 24-hour blood pressure based on ABPM (\< 130/80 mmHg)
Untreated hypertensive participants
Adults with elevated 24-hour blood pressure (≥130/80 mmHg) not receiving antihypertensive treatment.
Eligibility Criteria
The study population will consist of adults aged 18 to 65 years referred for ambulatory blood pressure monitoring (ABPM) as part of routine clinical evaluation at a specialized cardiovascular center. Participants will include both normotensive individuals and untreated hypertensive individuals, classified based on 24-hour ABPM measurements. The study will include both previously collected data and prospectively recruited participants evaluated using standardized protocols.
You may qualify if:
- Adults aged 18 to 65 years;
- Both sexes;
- Referred for ambulatory blood pressure monitoring (ABPM) as part of routine clinical evaluation;
- Not receiving antihypertensive medication at the time of assessment;
- Availability of valid 24-hour ABPM data;
- Availability of carotid-femoral pulse wave velocity (cf-PWV) measurement;
- Availability of fasting laboratory data, including glucose and triglycerides, for calculation of the triglyceride-glucose (TyG) index;
- Ability and willingness to provide written informed consent (for prospectively recruited participants).
You may not qualify if:
- Use of antihypertensive medication at the time of evaluation;
- Cardiac arrhythmias that may interfere with accurate blood pressure or pulse wave velocity measurements;
- Invalid or poor-quality ambulatory blood pressure monitoring (ABPM) recordings;
- Inability to obtain reliable carotid-femoral pulse wave velocity (cf-PWV) measurements;
- Presence of severe vascular disease or conditions affecting arterial waveform assessment;
- Missing essential clinical, laboratory, or hemodynamic data required for the primary analysis;
- Pregnancy;
- Refusal or inability to provide informed consent (for prospectively recruited participants).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hospital de Baselead
Study Sites (1)
Medicine School of SĂ£o JosĂ© do Rio Preto
SĂ£o JosĂ© do Rio Preto, SĂ£o Paulo, 15090-000, Brazil
Related Publications (27)
Chirinos JA, Segers P, Hughes T, Townsend R. Large-Artery Stiffness in Health and Disease: JACC State-of-the-Art Review. J Am Coll Cardiol. 2019 Sep 3;74(9):1237-1263. doi: 10.1016/j.jacc.2019.07.012.
PMID: 31466622RESULTVan Bortel LM, Laurent S, Boutouyrie P, Chowienczyk P, Cruickshank JK, De Backer T, Filipovsky J, Huybrechts S, Mattace-Raso FU, Protogerou AD, Schillaci G, Segers P, Vermeersch S, Weber T; Artery Society; European Society of Hypertension Working Group on Vascular Structure and Function; European Network for Noninvasive Investigation of Large Arteries. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens. 2012 Mar;30(3):445-8. doi: 10.1097/HJH.0b013e32834fa8b0.
PMID: 22278144RESULTParati G, Stergiou G, O'Brien E, Asmar R, Beilin L, Bilo G, Clement D, de la Sierra A, de Leeuw P, Dolan E, Fagard R, Graves J, Head GA, Imai Y, Kario K, Lurbe E, Mallion JM, Mancia G, Mengden T, Myers M, Ogedegbe G, Ohkubo T, Omboni S, Palatini P, Redon J, Ruilope LM, Shennan A, Staessen JA, vanMontfrans G, Verdecchia P, Waeber B, Wang J, Zanchetti A, Zhang Y; European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens. 2014 Jul;32(7):1359-66. doi: 10.1097/HJH.0000000000000221.
PMID: 24886823RESULTO'Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G, Clement D, de la Sierra A, de Leeuw P, Dolan E, Fagard R, Graves J, Head GA, Imai Y, Kario K, Lurbe E, Mallion JM, Mancia G, Mengden T, Myers M, Ogedegbe G, Ohkubo T, Omboni S, Palatini P, Redon J, Ruilope LM, Shennan A, Staessen JA, vanMontfrans G, Verdecchia P, Waeber B, Wang J, Zanchetti A, Zhang Y; European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013 Sep;31(9):1731-68. doi: 10.1097/HJH.0b013e328363e964.
PMID: 24029863RESULTMuntner P, Shimbo D, Carey RM, Charleston JB, Gaillard T, Misra S, Myers MG, Ogedegbe G, Schwartz JE, Townsend RR, Urbina EM, Viera AJ, White WB, Wright JT Jr. Measurement of Blood Pressure in Humans: A Scientific Statement From the American Heart Association. Hypertension. 2019 May;73(5):e35-e66. doi: 10.1161/HYP.0000000000000087.
PMID: 30827125RESULTJohnson AW, Hissen SL, Macefield VG, Brown R, Taylor CE. Magnitude of Morning Surge in Blood Pressure Is Associated with Sympathetic but Not Cardiac Baroreflex Sensitivity. Front Neurosci. 2016 Sep 8;10:412. doi: 10.3389/fnins.2016.00412. eCollection 2016.
PMID: 27660603RESULTBilo G, Grillo A, Guida V, Parati G. Morning blood pressure surge: pathophysiology, clinical relevance and therapeutic aspects. Integr Blood Press Control. 2018 May 24;11:47-56. doi: 10.2147/IBPC.S130277. eCollection 2018.
PMID: 29872338RESULTRenna NF, Ramirez JM, Murua M, Bernasconi PA, Repetto JM, Verdugo RA, Farez BG, Miatello RM, Diez ER. Morning blood pressure surge as a predictor of cardiovascular events in patients with hypertension. Blood Press Monit. 2023 Jun 1;28(3):149-157. doi: 10.1097/MBP.0000000000000641. Epub 2023 Apr 13.
PMID: 37058087RESULTBooth JN 3rd, Jaeger BC, Huang L, Abdalla M, Sims M, Butler M, Muntner P, Shimbo D. Morning Blood Pressure Surge and Cardiovascular Disease Events and All-Cause Mortality in Blacks: The Jackson Heart Study. Hypertension. 2020 Mar;75(3):835-843. doi: 10.1161/HYPERTENSIONAHA.119.14233. Epub 2020 Feb 3.
PMID: 32008430RESULTBombelli M, Fodri D, Toso E, Macchiarulo M, Cairo M, Facchetti R, Dell'Oro R, Grassi G, Mancia G. Relationship among morning blood pressure surge, 24-hour blood pressure variability, and cardiovascular outcomes in a white population. Hypertension. 2014 Nov;64(5):943-50. doi: 10.1161/HYPERTENSIONAHA.114.03675. Epub 2014 Aug 25.
PMID: 25156170RESULTKario K. Morning surge in blood pressure and cardiovascular risk: evidence and perspectives. Hypertension. 2010 Nov;56(5):765-73. doi: 10.1161/HYPERTENSIONAHA.110.157149. Epub 2010 Oct 11. No abstract available.
PMID: 20937968RESULTKario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, Murata M, Kuroda T, Schwartz JE, Shimada K. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation. 2003 Mar 18;107(10):1401-6. doi: 10.1161/01.cir.0000056521.67546.aa.
PMID: 12642361RESULTWakabayashi I, Daimon T. The "cardiometabolic index" as a new marker determined by adiposity and blood lipids for discrimination of diabetes mellitus. Clin Chim Acta. 2015 Jan 1;438:274-8. doi: 10.1016/j.cca.2014.08.042. Epub 2014 Sep 6.
PMID: 25199852RESULTLiu H, Meng C, Wang Z, Liu C, Yu C, Li Z. Association of Novel Insulin Resistance Indices with Blood Pressure in New-Onset Hypertension and Elevated Blood Pressure Individuals: A Cross-Sectional Study. Diabetes Metab Syndr Obes. 2023 Dec 5;16:3953-3965. doi: 10.2147/DMSO.S432049. eCollection 2023.
PMID: 38077484RESULTThomas DM, Bredlau C, Bosy-Westphal A, Mueller M, Shen W, Gallagher D, Maeda Y, McDougall A, Peterson CM, Ravussin E, Heymsfield SB. Relationships between body roundness with body fat and visceral adipose tissue emerging from a new geometrical model. Obesity (Silver Spring). 2013 Nov;21(11):2264-71. doi: 10.1002/oby.20408. Epub 2013 Jun 11.
PMID: 23519954RESULTXuan W, Liu D, Zhong J, Luo H, Zhang X. Impacts of Triglyceride Glucose-Waist to Height Ratio on Diabetes Incidence: A Secondary Analysis of A Population-Based Longitudinal Data. Front Endocrinol (Lausanne). 2022 Jul 22;13:949831. doi: 10.3389/fendo.2022.949831. eCollection 2022.
PMID: 35937805RESULTSong K, Xu Y, Wu S, Zhang X, Wang Y, Pan S. Research status of triglyceride glucose-body mass index (TyG-BMI index). Front Cardiovasc Med. 2025 Jul 18;12:1597112. doi: 10.3389/fcvm.2025.1597112. eCollection 2025.
PMID: 40756600RESULTCui H, Liu Q, Wu Y, Cao L. Cumulative triglyceride-glucose index is a risk for CVD: a prospective cohort study. Cardiovasc Diabetol. 2022 Feb 10;21(1):22. doi: 10.1186/s12933-022-01456-1.
PMID: 35144621RESULTAvagimyan A, Pogosova N, Fogacci F, Aghajanova E, Djndoyan Z, Patoulias D, Sasso LL, Bernardi M, Faggiano A, Mohammadifard N, Neglia D, Carugo S, Cicero A, Rizzo M, Biondi-Zoccai G, De Caterina R, Sarrafzadegan N. Triglyceride-glucose index (TyG) as a novel biomarker in the era of cardiometabolic medicine. Int J Cardiol. 2025 Jan 1;418:132663. doi: 10.1016/j.ijcard.2024.132663. Epub 2024 Oct 18.
PMID: 39426418RESULTSimental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008 Dec;6(4):299-304. doi: 10.1089/met.2008.0034.
PMID: 19067533RESULTSchram MT, Henry RM, van Dijk RA, Kostense PJ, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Westerhof N, Stehouwer CD. Increased central artery stiffness in impaired glucose metabolism and type 2 diabetes: the Hoorn Study. Hypertension. 2004 Feb;43(2):176-81. doi: 10.1161/01.HYP.0000111829.46090.92. Epub 2003 Dec 29.
PMID: 14698999RESULTKalil GZ, Haynes WG. Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications. Hypertens Res. 2012 Jan;35(1):4-16. doi: 10.1038/hr.2011.173. Epub 2011 Nov 3.
PMID: 22048570RESULTVlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010 Mar 30;55(13):1318-27. doi: 10.1016/j.jacc.2009.10.061.
PMID: 20338492RESULTTownsend RR, Wilkinson IB, Schiffrin EL, Avolio AP, Chirinos JA, Cockcroft JR, Heffernan KS, Lakatta EG, McEniery CM, Mitchell GF, Najjar SS, Nichols WW, Urbina EM, Weber T; American Heart Association Council on Hypertension. Recommendations for Improving and Standardizing Vascular Research on Arterial Stiffness: A Scientific Statement From the American Heart Association. Hypertension. 2015 Sep;66(3):698-722. doi: 10.1161/HYP.0000000000000033. Epub 2015 Jul 9. No abstract available.
PMID: 26160955RESULTFranklin SS, Gustin W 4th, Wong ND, Larson MG, Weber MA, Kannel WB, Levy D. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation. 1997 Jul 1;96(1):308-15. doi: 10.1161/01.cir.96.1.308.
PMID: 9236450RESULTLewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002 Dec 14;360(9349):1903-13. doi: 10.1016/s0140-6736(02)11911-8.
PMID: 12493255RESULTArima H, Barzi F, Chalmers J. Mortality patterns in hypertension. J Hypertens. 2011 Dec;29 Suppl 1:S3-7. doi: 10.1097/01.hjh.0000410246.59221.b1.
PMID: 22157565RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jose F VILELA-MARTIN, PhD
Medicine School of SĂ£o JosĂ© do Rio Preto - SP - Brazil
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
May 2, 2026
First Posted
May 15, 2026
Study Start (Estimated)
July 1, 2026
Primary Completion (Estimated)
July 1, 2027
Study Completion (Estimated)
July 1, 2028
Last Updated
May 22, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will be available upon reasonable request to the corresponding author, following publication of the study results. Data sharing will be subject to approval by the responsible ethics committee and compliance with applicable data protection regulations. De-identified data may be shared for research purposes only, under a data use agreement to ensure participant confidentiality.